Medications for coronary artery disease
Pro Research Analysisby 
Searched over 200M research papers
Standard Medications for Coronary Artery Disease
The main medications used to treat coronary artery disease (CAD) include antiplatelet agents (like aspirin), statins, beta-blockers, angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARBs), and sometimes calcium channel blockers and aldosterone antagonists. These drugs are recommended for both stable CAD and acute coronary syndromes, regardless of whether patients undergo procedures like angioplasty or bypass surgery 2369.
Antiplatelet and Antithrombotic Therapy in CAD
Antiplatelet drugs, especially aspirin, are a cornerstone of CAD treatment. Clopidogrel is an alternative for those who cannot take aspirin. In certain cases, dual antiplatelet therapy (using two drugs) is used, especially after stent placement or acute coronary events. Anticoagulants and fibrinolytics may also be used in specific situations, but these increase bleeding risk, so the choice and duration of therapy must be carefully balanced 79.
Lipid-Lowering Agents: Statins and Beyond
Statins are the first-line lipid-lowering agents for all CAD patients unless contraindicated. Ezetimibe and PCSK9 inhibitors are additional options for patients who do not reach cholesterol targets with statins alone. New therapies targeting different lipid traits are emerging and may further improve outcomes in the future 139.
Antianginal Medications
Beta-blockers are the first choice for controlling angina (chest pain) in CAD. If symptoms persist, calcium channel blockers, nitrates, or ranolazine can be added. These medications help reduce the heart's workload and improve blood flow 39.
Role of Anti-Inflammatory Therapies
Chronic inflammation plays a key role in CAD progression. Some anti-inflammatory drugs, such as colchicine and canakinumab, have shown promise in reducing cardiovascular events, especially in high-risk patients already on standard therapy. However, these are not yet part of routine guidelines 14.
Managing Comorbidities and Risk Factors
Treating high blood pressure, diabetes, and other risk factors is essential in CAD management. Antihypertensive and antidiabetic medications are commonly prescribed alongside CAD-specific drugs 69.
Importance of Medication Adherence
Good adherence to prescribed medications significantly lowers the risk of death, heart attacks, and hospitalizations in CAD patients. Poor adherence is common and leads to worse outcomes. Strategies to improve adherence include clear communication from healthcare providers, patient education, and support during transitions in care 5810.
Real-World Drug Utilization Patterns
Studies show that most CAD patients receive a combination of antiplatelet, antihypertensive, and antidiabetic drugs, often alongside procedures like coronary angiography. Prescribing drugs by their generic names and using essential medicines lists are common practices in many healthcare settings .
Conclusion
Medications for coronary artery disease focus on reducing blood clot risk, lowering cholesterol, controlling symptoms, and managing risk factors. Adherence to these medications is crucial for preventing complications and improving survival. New therapies, especially those targeting inflammation and novel lipid pathways, may further enhance care in the future 1345+5 MORE.
Sources and full results
Most relevant research papers on this topic